Study assesses cost of overpayments for topical prescription medications


What The Study Did:

This study examined how common and at what cost is the practice of so-called “clawbacks” for topical prescription drugs when an insured patient’s copayment exceeds the insurer’s cost for the drug.


To access the embargoed study:

Visit our For The Media website at this link

https:/

/

media.

jamanetwork.

com/


Authors:

Joslyn Kirby, M.D., M.S., M.Ed., of the Penn State Milton S. Hershey Medical Center in Hershey, Pennsylvania, is the corresponding author.

(doi:10.1001/jamadermatol.2019.3078)


Editor’s Note:

Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

###


Media advisory:

The full study is linked to this news release.


Embed this link to provide your readers free access to the full-text article

This link will be live at the embargo time

https:/

/

jamanetwork.

com/

journals/

jamadermatology/

fullarticle/

10.

1001/

jamadermatol.

2019.

3078?guestAccessKey=

c5c178d0-6aee-4ff5-9256-81da7592f27a&utm_source=

For_The_Media&utm_medium=

referral&utm_campaign=

ftm_links&utm_content=

tfl&utm_term=

100919

This part of information is sourced from https://www.eurekalert.org/pub_releases/2019-10/jn-sac100719.php

JAMA Network Media Relations

mediarelations@jamanetwork.org
https://media.jamanetwork.com/

Leave a Reply

Your email address will not be published. Required fields are marked *